Concepedia

Xubo Shi

XS

Statistics

Publications

3

Citations

481

H-Index

3

Active since

2019

Affiliations

Inserm(Current)

Canadian VIGOUR Centre

State University of New York

Assistance Publique – Hôpitaux de Paris

Royal Brompton Hospital

Xubo Shi is an author at Inserm specializing in clinical cardiology, cardiovascular pharmacotherapy, and cardiovascular disease.

Publications per year

2019–2021

3

Publications

3

Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

Kausik K Ray, Helen M Colhoun, Michael Szarek et al. · The Lancet Diabetes & Endocrinology · 2019 · 328 citations · Full text

, , +15

Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol

Gregory G. Schwartz, Vera A. Bittner, Patricio López‐Jaramillo et al. · Journal of the American College of Cardiology · 2021 · 141 citations · Full text

, , +17

Higher Iodine Concentration Enables Radiation Dose Reduction in Coronary CT Angiography

Qing Zhang, Haifeng Mi, Xubo Shi et al. · Academic Radiology · 2020 · 12 citations · Full text

, , +12

1–3 of 3